CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF 3D Printing and Heart Failure: The Present and the Future A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Angiotensin–neprilysin inhibition versus enalapril in heart failure

Editorial17 Nov 201

JOURNAL:Circulation. Article Link

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

Martinez FA, Serenelli M, Nicolau JC et al. Keywords: dapagliflozin; HFrEF; efficacy; safety

FULL TEXT PDF